Hinge Health Inc. (NYSE:HNGE) Receives $101.93 Average PT from Analysts

Posted by George Bondi on Sep 16th, 2026

Shares of Hinge Health Inc. (NYSE:HNGE – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, fourteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $101.9286.

Several equities research analysts have weighed in on the stock. Wells Fargo & Company increased their target price on shares of Hinge Health from $90.00 to $103.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Robert W. Baird boosted their price target on shares of Hinge Health from $55.00 to $65.00 and gave the company a “neutral” rating in a report on Wednesday, June 17th. Zacks Research cut shares of Hinge Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hinge Health in a report on Monday, August 3rd. Finally, Citigroup reissued an “outperform” rating on shares of Hinge Health in a research note on Monday, July 27th.

View Our Latest Stock Analysis on HNGE

Insider Activity

In other Hinge Health news, Chairman Gabriel Mecklenburg sold 250,000 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $88.97, for a total transaction of $22,242,500.00. Following the sale, the chairman directly owned 250,000 shares in the company, valued at approximately $22,242,500. This trade represents a 50.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Insight Holdings Group, Llc sold 1,466,667 shares of Hinge Health stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $82.83, for a total transaction of $121,484,027.61. The SEC filing for this sale provides additional information. Insiders have sold 4,150,019 shares of company stock worth $335,841,156 in the last 90 days. Corporate insiders own 18.92% of the company’s stock.

Institutional Investors Weigh In On Hinge Health

Institutional investors have recently added to or reduced their stakes in the stock. IFP Advisors Inc lifted its stake in Hinge Health by 140.0% in the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after acquiring an additional 189 shares in the last quarter. Janney Montgomery Scott LLC grew its stake in shares of Hinge Health by 3.3% during the 1st quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company’s stock worth $362,000 after acquiring an additional 300 shares in the last quarter. Nykredit A S bought a new position in shares of Hinge Health during the 2nd quarter worth approximately $29,000. Lazard Asset Management LLC raised its holdings in shares of Hinge Health by 0.6% in the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock valued at $2,456,000 after purchasing an additional 386 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in shares of Hinge Health in the fourth quarter valued at approximately $26,000.

Hinge Health Trading Down 2.3%

Shares of HNGE opened at $92.61 on Wednesday. The stock has a market cap of $7.47 billion, a P/E ratio of 72.35 and a beta of 1.38. Hinge Health has a 1 year low of $30.08 and a 1 year high of $95.57. The stock’s 50-day moving average price is $86.33 and its two-hundred day moving average price is $64.89.

Hinge Health (NYSE:HNGE – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.31. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.The company had revenue of $212.82 million during the quarter. During the same period last year, the company earned $0.59 earnings per share. The business’s revenue was up 53.0% compared to the same quarter last year. As a group, equities analysts forecast that Hinge Health will post 1.25 EPS for the current year.

Hinge Health Company Profile

(Get Free Report)

Hinge Health, Inc is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.

Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians.